U.S. Medical Equipment Stock News

NYSE:ULS
NYSE:ULSProfessional Services

A Look At UL Solutions (ULS) Valuation After Strong Q1 2026 Results And ULTRUS UL 360 Launch

UL Solutions (ULS) is back in focus after reporting strong Q1 2026 results, highlighting margin expansion, productivity gains and operational efficiency, alongside the launch of its AI-powered ULTRUS UL 360 sustainability software. See our latest analysis for UL Solutions. That strength is showing up in the share price too, with a 90 day share price return of 40.34% and a 1 year total shareholder return of 40.33%, suggesting momentum has been building as ULTRUS UL 360 launches, hydrogen...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

How Investors May Respond To Tilray Brands (TLRY) Earnings Miss And Lyphe Group UK Acquisition

Tilray Brands recently reported a quarterly loss of $0.24 per share with revenue falling short of market expectations, while also completing its acquisition of UK-based Lyphe Group to expand its medical cannabis footprint and digital health capabilities in that market. This combination of weaker financial performance and a push into the UK medical cannabis ecosystem highlights management’s focus on using acquisitions to reshape Tilray’s international growth profile despite ongoing...
NasdaqGS:VNET
NasdaqGS:VNETIT

CATL’s US$1b Bet Recasts VNET As AI Data Center Player

CATL has agreed to invest nearly US$1b to acquire about 38% of VNET Group, shifting the company toward AI focused data center operations. The partnership keeps VNET’s founder in operational control while CATL gains a significant foothold in AI oriented data infrastructure. The deal aims to align VNET’s data center portfolio with rising demand for AI ready capacity in China. For investors tracking NasdaqGS:VNET, this move comes with the stock last closing at US$10.09 and showing strong multi...
NasdaqGS:INTR
NasdaqGS:INTRBanks

Is Inter & Co (INTR) Now Attractive After Recent Share Price Weakness?

Investors may be wondering if Inter & Co at around US$5.77 is starting to look attractive, or if the recent market mood is a signal to be more cautious with the stock. The share price is down 9.8% over the past week, 31.5% over the past month, and 31.7% year to date, following a 3-year return of about 2.6x. Recent coverage has focused on Inter & Co's position in the US listed banking space and how its digital banking model fits into investor expectations. There has also been commentary on...
NasdaqGS:AVT
NasdaqGS:AVTElectronic

Avnet IT Recognition And Farnell Margins Shape Investor Expectations

Avnet (NasdaqGS:AVT) CIO Max Chan has received the 2026 MIT Sloan CIO Leadership Award, recognizing his work in technology strategy and digital transformation. Avnet subsidiary Farnell has reported record operating margin expansion, its best operating margin performance in three years. These developments highlight both corporate IT execution at the group level and profitability improvement within a key distribution business. Avnet sits at the center of electronic components distribution and...
NasdaqGS:EZPW
NasdaqGS:EZPWConsumer Finance

Is EZCORP (EZPW) Still Attractively Valued After Strong Revenue And Earnings Growth?

EZCORP (EZPW) has drawn fresh attention after reporting second quarter and first half fiscal 2026 results, with higher revenue, net income and earnings per share compared with the prior year periods. See our latest analysis for EZCORP. Despite the earnings lift, EZCORP’s share price pulled back 4.3% over the last day and 4.9% over the past week. However, the 90 day share price return of 27.1% and 1 year total shareholder return of 132.9% suggest momentum has been strong over a longer...
NasdaqGS:HTFL
NasdaqGS:HTFLHealthcare Services

HeartFlow (HTFL) Valuation Check After Recent Share Price Volatility

HeartFlow (HTFL) has drawn investor attention after recent share price swings, with the stock up 3.7% on the day, but down 15.1% over the past month and 8.2% year to date. See our latest analysis for HeartFlow. That recent 1-day share price return sits against a 7-day share price return of down 9.6% and a 30-day share price return of down 15.1%, while the 90-day share price return of 12.3% hints at earlier momentum now fading. If HeartFlow’s swings have you thinking more broadly about...
NasdaqGS:AGYS
NasdaqGS:AGYSSoftware

Agilysys (AGYS) Net Margin Expansion Tests Premium P/E Growth Narrative

Agilysys (AGYS) has wrapped up FY 2026 with fourth quarter revenue of US$82.9 million and basic EPS of US$0.44, capping off a trailing twelve month run of US$319.3 million in revenue and basic EPS of US$1.39, alongside earnings growth of 67% over the past year. The company has seen quarterly revenue move from US$74.3 million in Q4 FY 2025 through to US$82.9 million in Q4 FY 2026, while quarterly basic EPS shifted from US$0.14 to US$0.44 over the same period. This may prompt investors to focus...
NYSE:CMP
NYSE:CMPMetals and Mining

Compass Minerals Lithium Pivot Links EnergyX Deal To CMP Valuation Risks

Compass Minerals International (NYSE:CMP) has partnered with EnergyX to develop a commercial-scale direct lithium extraction and refinery facility in the U.S. The project will use Compass Minerals' existing land and infrastructure at the Great Salt Lake. The partnership is designed to support domestic battery mineral supply chains and broaden Compass Minerals' business beyond salt and plant nutrition. Compass Minerals has historically focused on salt and plant nutrition products, so this...
NasdaqGS:IDXX
NasdaqGS:IDXXMedical Equipment

IDEXX SDMA Rollout Ties Earlier Kidney Detection To Valuation Debate

IDEXX Laboratories (NasdaqGS:IDXX) has integrated the SDMA kidney biomarker into its most widely used Catalyst in-clinic chemistry profiles. The update allows veterinarians in the US and Canada to detect kidney disease in pets earlier through routine bloodwork. Clinics can access SDMA testing without changing existing workflows or investing in separate assays. The move aligns the Catalyst platform with international veterinary kidney disease guidelines. IDEXX Laboratories focuses on...
NYSE:MTH
NYSE:MTHConsumer Durables

How Investors May Respond To Meritage Homes (MTH) Weather-Hit Q1 Miss And Tentative Spring Demand Rebound

In the past quarter, Meritage Homes reported Q1 revenue that missed analyst expectations, citing a severe winter storm and geopolitical tensions that weighed on demand and mortgage activity. The company also highlighted a pickup in spring selling-season interest, underscoring how external shocks can quickly alter consumer sentiment in an already affordability-challenged housing market. Next, we will examine how weaker-than-expected Q1 results tied to weather disruptions may influence...
NYSE:AMBP
NYSE:AMBPPackaging

What Ardagh Metal Packaging (AMBP)'s Margin Expansion Amid Softer Volumes Means For Shareholders

In recent days, Ardagh Metal Packaging reported strong Q1 2026 adjusted EBITDA growth and reaffirmed its full-year guidance, even as beverage can volumes dipped by 1% amid a tough macro backdrop. An interesting angle is that the company’s ability to expand margins despite slightly lower volumes suggests its cost discipline and pricing power are becoming more important drivers of performance than pure volume growth. We’ll now look at how Ardagh Metal Packaging’s margin improvement and...
NYSE:WTS
NYSE:WTSMachinery

Is It Time To Reassess Watts Water Technologies (WTS) After Recent Price Strength

If you are wondering whether Watts Water Technologies at around US$296 per share is still fairly priced or starting to look stretched, you are not alone. The stock is up 6.3% year to date and 22.3% over the last year, although it has slipped 1.3% over the past week and 2.1% over the past month, which may have some holders reassessing the balance of risk and reward. Recent news coverage has focused on Watts Water Technologies in the context of broader interest in industrial and infrastructure...
NasdaqCM:POET
NasdaqCM:POETSemiconductor

POET Technologies Lawsuits Put Tax Disclosures And AI Contracts In Focus

Multiple federal securities class action lawsuits have been filed against POET Technologies alleging misstatements regarding its U.S. PFIC tax status. The suits claim the company failed to disclose tax risks for U.S. investors and that confidentiality breaches by an executive led to the cancellation of a major order. Plaintiffs argue these issues harmed POET Technologies' business prospects and exposed shareholders to material legal and financial risks. For investors watching POET...
NasdaqGS:NUVL
NasdaqGS:NUVLBiotechs

Assessing Nuvalent (NUVL) Valuation After Recent Share Price Volatility And DCF Upside Signals

Nuvalent (NUVL) has drawn investor attention after recent share price moves, with the stock last closing at $101. With no revenue yet, the clinical-stage biopharma story rests on pipeline progress and ongoing trial outcomes. See our latest analysis for Nuvalent. Recent trading has been choppy, with the 1-day share price return of 1.10% contrasting with a 30-day share price decline of 6.14%. However, the 1-year total shareholder return of 33.10% and 3-year total shareholder return of about...
NasdaqCM:NKTR
NasdaqCM:NKTRPharmaceuticals

Nektar Names Linda Rubinstein CFO As Funding And Dilution Questions Loom

Nektar Therapeutics (NasdaqCM:NKTR) has appointed Linda Rubinstein as Chief Financial Officer. Rubinstein succeeds retiring CFO Sandra Gardiner and brings experience in large M&A and capital markets transactions. Nektar Therapeutics is drawing fresh attention with this leadership change, coming after a very large 1 year share price gain and a year to date return of 55.6%. The stock last closed at $67.58, even after declining 13.8% over the past week and 20.4% over the past month. For...
NYSE:HAL
NYSE:HALEnergy Services

Is It Too Late To Consider Halliburton (HAL) After A 116% One-Year Surge?

Wondering whether Halliburton at around US$42.98 is still priced for opportunity or already reflecting a lot of optimism, this article focuses squarely on what you are getting for the price you pay. The stock has shown strong recent moves, with returns of 3.1% over 7 days, 15.7% over 30 days, 45.2% year to date and 115.6% over 1 year, so valuation is front of mind for many investors. Recent coverage around Halliburton has centered on its role in the energy sector and investor interest in...
NYSE:OWL
NYSE:OWLCapital Markets

Blue Owl Deepens Insurance And GP Liquidity Push For Fee Stability

Blue Owl Capital (NYSE:OWL) appointed Deva Mishra as Head of Blue Owl Insurance Solutions, expanding its focus on insurance related investment capabilities. The company also broadened its GP Strategic Capital business with a multi layered liquidity platform designed to provide additional liquidity options for limited partners. For investors following NYSE:OWL, these moves sit at the intersection of private markets and insurance capital, two areas that have attracted sustained attention from...
NasdaqGS:CART
NasdaqGS:CARTConsumer Retailing

Assessing Maplebear Instacart (CART) Valuation As Investors Revisit Mixed Return Signals

Why Maplebear’s recent performance has investors watching more closely Maplebear (CART), better known as Instacart, has drawn fresh attention after recent trading, with the stock around $40.98 and returns mixed across different timeframes. This has prompted closer scrutiny of its fundamentals. See our latest analysis for Maplebear. Recent trading has been choppy around the current US$40.98 share price, with the 7 day share price return up 4.9% but the 1 year total shareholder return down 13%...
NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

Comcast Florida Broadband Push Puts Valuation And Earnings Outlook In Focus

Comcast (NasdaqGS:CMCSA) is expanding multi-gigabit broadband across parts of Florida through new public private partnerships. The buildout targets thousands of previously unserved homes and businesses, supported by the state’s Broadband Opportunity Program. The company is pairing network investment with digital inclusion efforts, including Internet Essentials and funding for local nonprofits. For you as an investor, this Florida broadband buildout sits right at the core of Comcast’s...
NYSE:HLX
NYSE:HLXEnergy Services

Is the Latest Oil Price Shock Altering the Investment Case for Helix Energy Solutions Group (HLX)?

In the past week, Helix Energy Solutions Group drew attention as crude oil prices rose above US$100 per barrel amid heightened geopolitical tensions and supply concerns, including drone attacks on a UAE nuclear facility and disruption around the Strait of Hormuz. This oil price shock highlighted how sensitive Helix’s business is to shifts in offshore activity and commodity markets that can quickly alter contract economics and project timing. We’ll now examine how this oil price spike and...
NYSE:LUXE
NYSE:LUXESpecialty Retail

LuxExperience B.V (NYSE:LUXE) Quarterly Loss Challenges Bullish Narrative Of Durable Profitability

LuxExperience B.V (LUXE) has reported Q3 2026 revenue of €618.5 million with a basic EPS loss of €0.22, compared with Q3 2025 revenue of €242.5 million and a basic EPS loss of €0.06. This sets up a quarter where top line scale meets thinner per share profitability. Over the past four reported quarters, revenue has ranged from €573.5 million to €646.9 million while quarterly basic EPS has moved between a loss of €0.61 and a profit of €4.98. This gives investors a wide band of outcomes to judge...
NYSE:DVA
NYSE:DVAHealthcare

Is It Too Late To Consider DaVita (DVA) After A 70% Year To Date Surge?

Investors may be wondering whether DaVita's share price still offers value after a strong run, or if most of the opportunity has already been priced in. The stock closed at US$194.61, with returns of 31.6% over the past month, 70.0% year to date and 33.5% over the past year. This naturally raises questions about growth potential and changes in perceived risk. Recent attention on DaVita has focused on how investors view the resilience of its dialysis business model and the long term demand...
NYSE:TREX
NYSE:TREXBuilding

Assessing Trex Company (TREX) Valuation After Q1 Earnings Beat And Major UK Campaign Launch

Trex Company (TREX) is back in focus after reporting first quarter results that exceeded revenue and EBITDA expectations, reaffirming its 2026 guidance and rolling out its largest UK marketing campaign, Make Life Outstanding. See our latest analysis for Trex Company. Despite the upbeat Q1 report, reaffirmed 2026 guidance and progress on its buyback, Trex’s share price has come under pressure, with a 1 month share price return of down 15.27% and a 1 year total shareholder return of down...